In the News CPHI South East Asia 2026: ORGANOPlus Showcases Proprietary Probiotic Strain OP820 Jul 13, 2026 ORGANOPlus presented Bifidobacterium adolescentis OP820 and its human gut-mimicking platform, VILLIORGAN™, at CPHI South East Asia 2026 in Bangkok. The company introduced its capabilities in probiotic strain discovery, functional validation, and collaborative product development for the Southeast Asian market. Go to the original article PreviousORGANOPlus Exhibits Human Validation Platform at BIO KOREA 2026NextAFPRO 2026: ORGANOPlus to Unveil VILLIORGAN™ for AI-Driven Livestock ESG Innovation Back to list
